Skip to main content
. 2023 Dec 14;130(3):417–424. doi: 10.1038/s41416-023-02514-5

Fig. 2. CONSORT diagram of PIPSeN.

Fig. 2

Among 180 enrolled patients, 60 presented with partial response after platinum-based induction chemotherapy and were randomized between olaparib (n = 33) and placebo (n = 27).